Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars
NCT ID: NCT05102318
Last Updated: 2022-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2020-04-01
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Different Materials in Pulpotomy of Primary Molars
NCT05981352
Regenerative Endodontics for Non-vital Primary Molars
NCT05098483
Bioactive Materials in Pulp Therapy of Primary Teeth
NCT04795830
Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth
NCT03589560
Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars
NCT05582317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic, Faculty of Dentistry, Ain shams University.
Subjects will be assigned randomly into two different treatment groups as follows:
MTA Group (1):
1. Group 1(A): MTA Direct Pulp Capping. (n=25)
2. Group 1 (B): MTA Partial Pulpotomy. (n=25)
3. Group 1 (C): MTA Complete Pulpotomy. (n=25)
BiodentineTM Group (2):
1. Group 2(A): BiodentineTM Direct Pulp Capping. (n=25)
2. Group 2 (B): BiodentineTM Partial Pulpotomy. (n=25)
3. Group 2 (C): BiodentineTM Complete Pulpotomy. (n=25)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Direct Pulp Capping with Biodentine
Direct Pulp Capping with Biodentine
Direct Pulp Capping
Direct Pulp Capping
Partial Pulpotomy with Biodentine
Partial Pulpotomy with Biodentine
Partial Pulpotomy
Partial Pulpotomy
Pulpotomy with Biodentine
Pulpotomy with Biodentine
Pulpotomy
Pulpotomy
Direct Pulp Capping with MTA
Direct Pulp Capping with MTA
Direct Pulp Capping
Direct Pulp Capping
Partial Pulpotomy with MTA
Partial Pulpotomy with MTA
Partial Pulpotomy
Partial Pulpotomy
Pulpotomy with MTA
Pulpotomy with MTA
Pulpotomy
Pulpotomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Direct Pulp Capping
Direct Pulp Capping
Partial Pulpotomy
Partial Pulpotomy
Pulpotomy
Pulpotomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of periapical or interadicular radiolucencies, inflammatory root resorption, sinus tract or gingival abscess.
Exclusion Criteria
* Children suffering from any physically or mentally disability that will complicate the treatment: Special Health Care needs (SHCN).
* Teeth of poor prognosis due to presence of an abscess or a sinus, mobility, advanced bone or root resorption or Non-Restorable teeth.
4 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
British University In Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Magdy
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noha Kabil, Professor
Role: STUDY_DIRECTOR
British University In Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ain Shams University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.